Up next

Autoplay

Tamoxifen lowered breast cancer rates among high-risk women

1 Views • 08/26/25
Share
Side Effects
Side Effects
Subscribers
0

Visit http://www.ecancer.org for more.

Prof Cuzick (Wolfson Institute of Preventive Medicine, London, UK) talks to ecancertv at SABCS 2014 about the results of the IBIS-I trial which looked at the long-term risks and benefits of taking tamoxifen to prevent breast cancer in women at high risk for developing the disease.

Read the news story or watch the press conference for more. Also see commentary from Prof Carlos Arteaga.

Show more
0 Comments sort Sort By

Up next

Autoplay